DKC1 and neuroblastoma: DKC1 overexpression has been reported in many cancers, including neuroblastoma, lymphoma, melanoma, colorectal cancer, ovarian carcinoma, breast cancer and hepatocellular carcinoma [101–109], and often results in poor prognosis due to aggressive tumor growth and resistance to therapy [104, 106, 110].